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ABSTRACT
Biopharmaceutical products are drugs that are made from living cells. One protein
type of high importance to biopharmaceuticals is monoclonal antibodies. Monoclonal
antibodies allow for highly specific, targeted treatment of diseases and detection of
molecules related to diseases. With major roles in detecting and/or treating diseases like
human immunodeficiency virus (HIV), coronavirus disease 2019 (COVID-19), and some
cancers, monoclonal antibodies are in demand. This demand has led to a need for
efficient cell culture systems to produce high yields of protein with minimal waste. The
most commonly used cell culture system for these high-value proteins is Chinese hamster
ovary (CHO) cells. Understanding and modifying CHO cell culture conditions can
improve culture productivity.
Previous research by Freund et al. (2018) presented a simple means to adapt cells
to elevated lactate concentrations to reduce waste product buildup, increase protein
productivity, and improve growth. It was also observed that the lactate-adapted cells had
lower lactate accumulation. However, the lactate-adaptation process that Freund et al.
(2018) used was stressful, as significant growth retardation was observed during the
process. The work presented in this thesis developed a less stressful method to adapt
CHO cells to elevated lactate concentrations The lactate adaptation was achieved by
serial passages of the CHO cells into incrementally higher lactate concentrations.
Batch cultures were used to compare the lactate-adapted cell growth characteristics
to unadapted cells. Cell densities, metabolic indicators, and amino acid profiles were
obtained daily for two lactate-adapted cell lines and unadapted cells. The lactate-adapted
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cells were cultured in elevated lactate equal to the final lactate-adaptation levels.
Additionally, the unadapted and lactate-adapted cells were cultured in the standard
media. It was observed that the elevated lactate was used by the lactate-adapted cells late
in the cultures instead of alanine. This alteration in metabolism resulted in lower
ammonia levels for the lactate-adapted cultures in elevated lactate compared to both
lactate-adapted and the unadapted cultures in standard media. Thus, elevated lactate can
have a positive effect on metabolism for lactate-adapted cells.
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CHAPTER ONE
1
1.1

INTRODUCTION

Significance
Biotechnology encompasses the use of recombinant technology for the production

of therapeutic proteins and other industrial enzymes. Commonly referred to as
biopharmaceuticals, therapeutic proteins are a multibillion-dollar industry and account for
over half of the biotechnology market (Kalorama Information, 2018b).
Biopharmaceuticals are recombinantly produced by several host organisms with the vast
majority being produced by Chinese hamster ovary (CHO) cells (Kalorama Information,
2018a). CHO cell cultures are used to manufacture therapeutic proteins, where the most
common type are monoclonal antibodies (mAbs). In addition to therapies, mAbs are used
as research tools and diagnostics (Kalorama Information, 2018b). CHO cells have several
advantages over other host organisms, including robust growth and human-like
glycosylation of proteins (Fischer, Handrick, & Otte, 2015). These attributes allow for
scalable production of safe and effective therapeutic proteins for intravenous delivery in
humans. Because of the success of CHO cell systems and the high demand for
biopharmaceuticals, it is beneficial to better understand the metabolism of CHO cells to
improve protein production.
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A significant mechanism towards gaining a better understanding of CHO cells is
its glucose consumption. High glucose consumption in CHO cell cultures often results in
lactate accumulation. Lactate is toxic to cells above concentrations of 40 mM and
negatively impacts protein production at concentrations as low as 20 mM (Hauser &
Wagner, 1997). Successful industrial processes have lactate production followed by
lactate consumption during cell growth (Mulukutla, Yongky, Grimm, Daoutidis, & Hu,
2015). The shift from lactate production to consumption is desirable but not fully
understood. Significant research has been conducted to reduce lactate production, but the
effectors of the lactate shift are not fully understood. This work investigated lactate
metabolism in cells adapted to high lactate (>20 mM) as a means to better understand the
mechanism of lactate consumption.
1.2

Organization
This Master’s thesis is divided into four chapters: Chapter 1 outlines the

background and motivation for this research and provides the organization of the thesis.
Chapter 2 contains a literature review on biopharmaceutical production, CHO cells, CHO
cell metabolism, and culture stressors. Chapter 3 contains the materials and methods and
experimental results. Chapter 4 summarizes the work and discusses possible future work.
The Appendix contains the amino acid concentration profiles for the five culture
conditions with the lactate-adapted (LA) and unadapted CHO cells. Additionally, growth
profiles are provided for previous work with unadapted CHO cells under lactate stress.
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CHAPTER TWO
2
2.1

LITERATURE REVIEW

Biotechnology
Biotechnology is defined as “any technological application that uses biological

systems, living organisms, or derivatives thereof, to make or modify products or
processes for specific use” (O'Grady, 2013). It is a widespread industry that reaches
across several different markets. The field impacts medicine, agriculture, environmental
approaches, and foods (Verma, Agrahari, Rastogi, & Singh, 2011). Biotechnology has
developed from increasing knowledge of biology and genetics. Historically, conventional
biotechnology referred to using animals or other living organisms to achieve outcomes,
such as with selective breeding or making bread with yeast (Gupta, Sengupta, Prakash, &
Tripathy, 2016). Following the discovery of the function, structure, and replication
mechanisms of DNA, it became possible to manipulate genetic material to achieve
desired results (Verma et al., 2011). With rapid advancements in molecular biology
techniques and capabilities, modern biotechnology became known more specifically for
its work with living cells or products from cells. With the goal to improve human health,
the biopharmaceutical field is a major subsection of biotechnology that focuses on
therapeutics and diagnostics using recombinant DNA technology.
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2.2

Biopharmaceutical Industry
The field of biopharmaceuticals emerged from the race to produce recombinant

insulin, a vital protein in the body that regulates blood sugar levels. Altered production or
response to insulin within the body results in diabetes. Exogenous insulin was found to be
an effective treatment for diabetes; therefore, the protein was harvested from animal
pancreases for several decades (Quianzon & Cheikh, 2012). It was clear this method for
acquiring insulin was not sustainable to meet rapidly increasing demands. Genentech and
Eli Lilly worked together to produce recombinant human insulin, which was licensed in
1982 as Humulin (Burrill, 2014; Quianzon & Cheikh, 2012). After Humulin was
approved by the United States Food and Drug Administration (FDA), the
biopharmaceuticals field rapidly developed.
Biopharmaceutical products are medicines produced using recombinant DNA
technology (Kesik-Brodacka, 2018). Recombinant DNA refers to the insertion of genetic
material from one organism into a different organism to obtain expression or product
formation (Khan, S. et al., 2016). Biopharmaceuticals differ from chemically synthesized
medicines due to the larger sizes, higher complexity, and increased specificity, in
addition to using a cell to manufacture the product (Rader, 2008). Biopharmaceuticals
now includes therapeutic proteins that are novel, also called biobetters (Kesik-Brodacka,
2018).
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Monoclonal antibodies (mAbs) are a specific group of therapeutic proteins that
make up a large portion of the therapeutic protein market. The structure of mAbs has led
to the development of therapeutics that target very specific molecules. MAb therapeutics
have been designed to bind to signaling proteins in a patient and eliminate harmful cells
and viruses. The development of mAbs has also increased the success for treatment of
several cancers (Kalorama Information, 2018b). MAb development continues to be
primarily focused on disease treatments.
The biopharmaceutical market continues to grow, with an expected growth over
the next five years in part due to coronavirus disease 2019 (COVID-19) (Curran, 2021).
Because of uncertainty in the economic market during the COVID-19 pandemic in 2020,
the biotechnology market had a 7.42% decrease in industry revenue in the United States
(Curran, 2021); however, this observed decrease was mainly attributed to nonbiopharmaceutical companies (Curran, 2021). Within the biotechnology market in the
United States, human health technologies accounts for 65.2% of the industry revenue at
$88.21 billion (Curran, 2021). The human health technologies sector includes
biopharmaceuticals along with other genetic technologies such as gene therapy and
pharmacogenomics (Curran, 2021). Over the next five years, the biotechnology market is
predicted to have a 3.0% annual growth rate (Curran, 2021). Much of the predicted
growth is attributed to an increased need of therapeutic proteins, such as mAbs, due to the
greater life expectancy in the United States and COVID-19 diagnostics and treatments.
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2.2.1

Chinese Hamster Ovary (CHO) Cells
Biopharmaceuticals are produced through several different expression systems

including bacteria, yeast, and animal cells. Choice of expression system depends on the
desired product and the simplest and cheapest means of obtaining that product. Bacterial
and yeast systems have the advantages of rapid growth and inexpensive cultivation, but
can make proteins that are improperly folded and/or lack critical post-translational
modification (Kalorama Information, 2018a). Mammalian cells are most commonly used
for biopharmaceuticals to harness the more complex protein synthesis and posttranslational modification capabilities of these cells (Lim et al., 2010). Cell lines that
have been studied include CHO, Vero (green African monkey kidney cells), HeLa cells
(human cervical carcinoma), and HEK293 (human embryonic kidney cells) (Dumont,
Euwart, Mei, Estes, & Kshirsagar, 2016; Khan, K. H., 2013).
CHO cells are the most frequently used for host therapeutic protein production.
CHO cells originate from cells isolated by Theodore Puck in 1956 (Puck, Cieciura, &
Robinson, 1958). The advantages that CHO cells provide over other mammalian hosts
include its robust growth in chemically-defined and serum-free media, suspension
adaptability, lower susceptibility to human pathogenic viruses, and capability for humanlike protein post-translation modifications (Fischer et al., 2015). Approximately 60-70%
of all recombinant therapeutic proteins on the market are produced by CHO cells
(McAtee, Templeton, & Young, 2014).
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2.2.2

CHO Cell Culture Challenges
CHO cell media is expensive, and long-duration cultures can be costly to maintain

(Kalorama Information, 2018a). Further, compared with bacterial and yeast expression
systems, CHO cells exhibit low productivity and final product concentrations (Vergara et
al., 2018). Research on CHO cells continues to develop methods to reduce production
costs and increase protein yields. A major impediment to high protein yields is toxic
byproduct accumulation, such as from lactate and ammonia. These byproducts largely
originate from metabolic pathways, which are not fully understood. Mitigation of
inhibitory byproducts such as lactate offers a promising strategy to improve final CHO
cell culture titer yield.
2.3

Culture Stressors
Culture stressors are important to identify. Stressors may originate from the

culture media, which enhances byproduct accumulation, or from physical issues, such as
shear stress or poor oxygenation. Knowledge of cell metabolism mechanisms and
identification of stressors are important to developing stressor mitigation measures. Much
work has been conducted to identify two stressors related to the culture media
formulation, lactate and ammonia (Cruz, Freitas, Alves, Moreira, & Carrondo, 2000;
Freund & Croughan, 2018; Zhang, Yi, Sun, & Zhang, 2006). Lactate concentrations are
widely connected to glucose consumption, and ammonia buildup is connected to
glutamine and other amino acid consumption (Pereira, Kildegaard, & Andersen, 2018).
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Glucose is the main energy source for CHO cells. Glucose is present in the batch
media, but also needs to be independently fed to cell cultures from concentrated stocks
for fed-batch cultures. CHO cell metabolism is inefficient, such that high glucose
concentration leads to the formation of waste products (Pereira et al., 2018). Under
aerobic conditions, the carbons from glucose are serially metabolized via glycolysis and
the tricarboxylic acid cycle (TCA) to generate intermediates, CO2, and energy. The
intermediates from glucose metabolism are used to form the amino acids that form
biomass and the recombinant protein, such as monoclonal antibodies. An attribute of
inefficient metabolism is the generation of lactate from glucose in glycolysis.
Specifically, lactate is produced from pyruvate that is generated during glycolysis.
In culture, lactate concentrations exceeding 20 mM result in lower protein productivity,
while lactate concentrations exceeding 40 mM are considered inhibitory to growth
(Hauser & Wagner, 1997). Usually, lactate production is observed early in the culture,
and lactate consumption occurs late in the culture. If this shift does not occur, culture
growth and productivity can be hindered (Li, Wong, Vijayasankaran, Hudson, &
Amanullah, 2012). Lactate as low as 25 mM has been shown to prevent the shift to
lactate consumption, resulting in higher final lactate accumulation (Mulukutla et al.,
2015). Because of its adverse effects, it is important to gain a better understanding of
lactate accumulation effectors.
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Glutamine functions as both a primary nitrogen source for CHO cells and a
carbon source. Glutamine enters the TCA cycle via α-ketoglutarate. Chemical
degradation and metabolic consumption of glutamine, as well as other amino acids,
produces ammonium as a byproduct (Adeva-Andany et al., 2014; Chen & Harcum, 2005;
Pereira et al., 2018). Ammonium concentrations as low as 10 mM have been observed to
be associated with apoptosis and poor protein production (Andersen & Goochee, 1994).
In addition to growth and protein productivity inhibition, elevated ammonia has been
observed to negatively affect protein post-translational modifications, which can affect
function, stability, and/or immunogenicity (Andersen & Goochee, 1994; Andersen &
Goochee, 1995; Cruz et al., 2000). Ammonia and lactate are often monitored together, as
decreases in lactate accumulation often coincide with increased ammonia accumulation
and vice versa (Li et al., 2012; Zhang et al., 2006).
In addition to direct metabolic effects, lactate and ammonium production are
associated with increased osmolality and decreased pH (Slivac, Blajić, Radošević,
Kniewald, & Gaurina Srček, 2010). Osmolality increases in response to lactate
accumulation due to base additions to control pH (Lao & Toth, 1997; Martínez et al.,
2013). Hyperosmotic cultures have been reported to have inhibited growth and lower
titers (Alhuthali, Kotidis, & Kontoravdi, 2021). Ammonia accumulation also lowers pH,
by interacting with the cell membrane potential (Oguchi, Saito, Tsukahara, & Tsumura,
2006). Increasing the buffer capacity of culture media to mitigate pH changes results in
media with higher osmolarity (Ahleboot et al., 2021). Therefore, pH and osmolality in
conjunction with lactate and ammonia are highly interdependent.
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2.4

Lactate Control Methods
Lactate production followed by lactate consumption is desired for CHO cell

cultures. Typically, lactate production occurs during exponential growth, while lactate
consumption occurs after glutamine is depleted. One approach to control lactate
accumulation has been termed the high-end pH-controlled delivery of glucose
(HIPDOG). This approach uses increasing culture pH as an indicator of low glucose due
to lactate consumption (Gagnon et al., 2011). The HIPDOG approach feeds glucose in
response to pH increases caused by lactate consumption, which is acidic. Then, when
lactate production occurs due to high glucose, the pH decreases, and the glucose feed is
stopped. With the HIPDOG approach, overall lactate accumulation was reduced, and
protein production was higher than control cultures (Gagnon et al., 2011). While this
approach reduced lactate accumulation and increased protein production, it required the
initial lactate to be slightly elevated (~5 mM).
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Since lactate accumulation negatively impacts culture performance, methods to
decrease lactate accumulation that can be translated to industrial-sized bioreactors are
desired. Another approach to control lactate accumulation was to adapt cells to higher
lactate concentrations (Freund & Croughan, 2018). Specifically, Freund adapted cells to
elevated lactate in one step. Cells were directly placed in 35 mM lactate until a normal
growth rate was reached, about 40 days (Freund & Croughan, 2018). These LA-CHO
cells were then cultured in a fed-batch system in 40 mM lactate supplemented media.
These LA cells had lower lactate production rates. However, the LA cells were not
directly assessed in comparison to unadapted cells in terms of growth and titer, nor were
other metabolite concentrations such as amino acids reported. In this thesis work
described here, a set of serially lactate adapted cells were generated to investigate the
metabolism of LA cells versus unadapted cells.
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CHAPTER THREE
3
3.1

MATERIALS AND METHODS

Cell Line
The CHO cell line in this study was donated by the Vaccine Research Center at

the National Institute of Health (NIH). The CHO-K1 Clone A11 cell line expresses the
monoclonal antibody VRC01, which is an IgG1 anti-HIV mAb.
3.2

Media
CHO cell cultures were grown in ActiPro (Cytiva, Marlborough, MA). Powdered

media was formulated according to the manufacturer’s instruction. A 200 mM glutamine
stock (Sigma-Aldrich, St. Louis, MO) was added to the media to obtain a final
concentration of 6 mM. To generate the lactate containing medias, a high lactate ActiPro
media (100 mM lactate) was prepared with the addition of sodium lactate powder
(Sigma-Aldrich, St. Louis, MO) to the powdered ActiPro. To obtain the final lactate
concentrations required for the lactate-adaptation phase and growth in studies in elevated
lactate, standard ActiPro was mixed with 100 mM lactate ActiPro. For example, one part
standard ActiPro was mixed with nine parts 100 mM lactate ActiPro to obtain 10 mM
lactate ActiPro.
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3.3

Lactate-Adaptation Protocol
Cells were cultured in 125 mL baffled, vented shake flasks (VWR®, Radnor, PA)

in a 5% CO2 incubator at 37°C with an agitation speed of 180 rpm (0.75 inch throw).
CHO VRC01 cells were rapidly thawed from liquid nitrogen stocks into 30 mL of
standard ActiPro and cultured for three days. The unadapted CHO cells were then
cultured in the 10 mM lactate ActiPro media. All seeded densities targeted 5 x 105
cells/mL. For the cells to be considered lactate-adapted to a particular concentration,
three criteria were used: 1) the culture growth rate in the elevated lactate media was
equivalent to the growth rate in ActiPro, 2) the viable cell density (VCD) on Day 3 was at
least 4 x 106 cells/mL, and 3) the cultures obtained criteria 1) and 2) for three passages.
When cells were lactate-adapted, frozen stocks were made. Stock cultures were frozen in
10% dimethyl sulfoxide (DMSO) and stored in a liquid nitrogen tank. The LA cells were
then cultured in media at the next lactate concentration increment. This procedure was
repeated at 10 mM increments until stock cultures were obtained for 10 mM to 60 mM
lactate.
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3.4

LA Culture Characterization
Similar shake flasks and culture conditions to the lactate-adaptation protocol were

used for the batch cultures. The two LA (30 mM and 50 mM) and the unadapted cells
were used for the characterization studies. Frozen stocks were rapidly thawed into 30 mL
of ActiPro with respective lactate concentration. After three days, cells were seeded at 5 x
105 cells/mL into the test media. Table 3.1 outlines media conditions used for each LA
culture. All five conditions were conducted simultaneously. All conditions were
examined in triplicate, which were conducted serially, from new frozen stock culture.

Table 3.1: Experimental Conditions

0 mM

Cells
30 mM
LactateAdapted
0 mM

50 mM
LactateAdapted
0 mM

-

30 mM

50 mM

Unadapted
Media
Lactate
Concentration
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3.5

VCD, Metabolites, and Amino Acid Quantification
Daily samples were collected from the batch culture for VCD, metabolite

analysis, and amino acid quantification. VCD and cell viability were measured
immediately using a Vi-CELLTM XR Cell Viability Analyzer (Beckman Coulter, Brea,
CA). The cells were removed by centrifugation at 10,000 x g for 10 minutes. The culture
supernatant was collected for metabolite and amino acid analysis and stored at -20°C.
Measurements for glucose, lactate, glutamine, glutamate, IgG, and ammonia were
obtained using the Cedex Bio Analyzer (Roche Diagnostics, Basel, Switzerland). Amino
acid concentrations were obtained by capillary electrophoresis with high pressure mass
spectrometry (CE-HPMS) using the REBEL (908 Devices, Boston, MA) except for
glutamine and glutamate. Samples were diluted 1/100 in Rebel diluent for analysis on the
Rebel.
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3.6
3.6.1

Results and Discussion
Lactate Adaptation
To adapt CHO cells to higher lactate concentration, cells were cultured in

increasing lactate concentrations using 10 mM increments (10 mM to 60 mM lactate).
Figure 3.1 shows the growth profiles for the serial lactate-adaptation process versus time
in days. During the lactate-adaptation process up to 20 mM lactate, the cells had fairly
normal growth rates and final VCD on Day 3 despite the higher lactate concentration.
The adaptation time increased for the 30 to 40 mM lactate cultures by an additional threeday passage. The total time to reach 40 mM LA cells was about 42 days. The total time to
reach 60 mM LA cells was 76 days. The 30 mM and 50 mM LA cells were used for the
characterization study, in parallel with unadapted cells. A previous strategy described by
Freund et at. (2018) differed by placing CHO cells directly into 35 mM lactate media and
waiting for the cells to return to normal growth rates. This lactate adaptation process took
40 days. Although the growth rates returned, it was not specified if there was a VCD
criteria for adaptation. Since the growth rates and VCD were fairly constant during the
serial lactate adaptation, one can assume this process might be less stressful than directly
culturing cells in elevated lactate and waiting for normal growth rates to return.
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Figure 3.1: Growth Profiles for the Lactate-Adaptation Process. The lactate concentration in
ActiPro media was increased in increments of 10mM.

3.6.2

Cell Growth
Previous studies on LA cells showed that 35 mM LA cells had lower lactate

production when cultured in media with an initial lactate concentration of 40 mM. This
report did not directly compare the growth characteristics of the LA cells to unadapted
cells such that metabolic changes beyond lactate and ammonia were not determined. In
this study, two LA (30 mM and 50 mM lactate) and the unadapted cells were cultured in
ActiPro and ActiPro with equivalently elevated lactate (see Table 3.1 for media lactate
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concentration by LA cell type). Since Freund observed reduced lactate production with
35 mM LA cells, the 30 mM and 50 mM LA cells were expected to have reduced lactate
production and consume lactate later in the cultures.
Growth profiles for the five conditions are shown in Figure 3.2A. All cultures in
this work had growth rates of 0.031 ± 0.02 h-1 (SE) for the exponential phase. The growth
rate between Days 4 and 5 decreased for all cultures as the glucose became limiting (Fig
3.2B). The final VCD for the unadapted cells and the 30 mM and 50 mM LA cells in the
standard ActiPro media were similar. The 30 mM LA cells in 30 mM lactate ActiPro and
50 mM LA cells in 50 mM lactate ActiPro had a lower final VCD compared to unadapted
cells (p-value=0.0123) (see Appendix B-1A for the growth profile on a linear scale). The
cell viabilities for all the cultures were above 85% for the entire culture and were not
significantly different (p-value=0.067) (Fig 3.2C). The LA cells maintained growth in the
high lactate media, confirming lactate adaptation. The unadapted CHO cells were not
cultured in the elevated lactate media, as previous data demonstrated poor growth and
low titers under these conditions (Appendix C) (D. Chitwood, personal communication,
October 31, 2021). Further, other researchers have observed that unadapted CHO cells in
high lactate media have inhibited growth (Choi et al., 2007).
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The protein production for the unadapted cells was higher than the 30 mM and 50
mM LA cells in either media (p-value<0.0001) (Fig 3.2D). The LA cells clustered by
lactate adaptation and not the culture media. Previous research suggests that cells placed
in higher lactate concentrations exhibit higher protein yields but similar to normal
volumetric production rates (Choi et al., 2007; Lao & Toth, 1997). As it has been
demonstrated previously, lactate production and consumption impact protein production
(Freund & Croughan, 2018; Gagnon et al., 2011; Mulukutla et al., 2015). Despite the
gradual lactate adaptation, the LA cells appear to have been potentially negatively
impacted by the lactate adaptation process with respect to protein production. Fed-batch
culture would be needed to confirm these results and determine overall effect of lactate
adaptation on titer.
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A

B

C

D

Figure 3.2: Growth, Glucose, and Titer Profiles for Lactate-Adapted and
Unadapted Cells. A) VCD; B) Glucose. C) Cell Viability. D) Titer. “LA” = LactateAdapted. “/ 0” – ActiPro. “/ 30” – ActiPro with 30 mM Lactate initially. “/ 50” – ActiPro
with 50 mM Lactate initially. Error bars represent standard error.
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3.6.3

Metabolic Indicators and Products
To observe the effects of lactate adaptation on metabolism in standard and

elevated lactate media, several metabolites were monitored during the five-day batch
culture. Lactate and ammonia profiles are shown in Figures 3.3B and 3.4B, respectively.
The lactate concentrations for the cultures in the elevated lactate media are expectantly
higher than the cultures in standard media. For all cultures, the lactate profiles increased
between Day 0 and Day 3, indicating lactate production. The difference in lactate levels
during production between cultures were not significantly different (p-value=0.4300).
After Day 3, the lactate profiles decreased for all cultures, indicating lactate consumption.
There was a significant difference in the lactate consumption amounts with the elevated
lactate media cultures consuming more (p-value=0.0133). For the elevated lactate media
cultures, the amount of lactate consumed was greater than the amount of lactate
produced. Contrary to previous reports that lactate consumption was not possible in the
presence of glucose and excess lactate (Mulukutla et al., 2015), lactate consumption
occurred in this thesis work. The shift from lactate production to lactate consumption
aligns with the depletion of glutamine (Fig 3.3A). These results indicate that glutamine
plays a significant role in lactate production and consumption. Since the glutamine
consumption profile appears similar across the different cells and lactate level in the
media, it does not appear that the lactate adaptation and lactate levels in the media
affected glutamine metabolism.
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Interestingly, the ammonia profiles also have two distinct phases for all five
culture conditions. For all cultures, ammonia production occurred initially. For the 50
mM cells in 50 mM lactate, the ammonia production phase was one day longer than the
other culture conditions. After Day 4, the cultures in elevated lactate had constant
ammonia concentrations. In contrast, in standard media, both the LA and unadapted
cultures produced ammonia after Day 4. There was a significant difference in the final
ammonia values (p-value=0.0002). Decreased ammonia production has been previously
observed for LA cells (Lao & Toth, 1997). Thus, it appears that lactate adaptation
changed later-phase ammonia production when LA cells were cultured in elevated lactate
media.
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A

Figure 3.3: Glutamine, Lactate,

B

and Glutamate Profiles for
Lactate-Adapted and Unadapted
Cells. A) Glutamine; B) Lactate. C)
Glutamine. “LA” = Lactate-Adapted.
“/ 0” – ActiPro. “/ 30” – ActiPro with
30 mM Lactate initially. “/ 50” –
ActiPro with 50 mM Lactate initially.

C
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Error bars represent standard error.

A

B

Figure 3.4: Alanine and Ammonia Profiles for Lactate-Adapted and Unadapted
Cells. A) Alanine; B) Ammonia. “LA” = Lactate-Adapted. “/ 0” – ActiPro. “/ 30” –
ActiPro with 30 mM Lactate initially. “/ 50” – ActiPro with 50 mM Lactate initially.
Error bars represent standard error.
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3.6.4

Amino Acids
Since lactate and ammonia metabolism are related through glycolysis and the

TCA cycle, and protein synthesis requires adequate amino acids, the media amino acids
were quantified. Most of the amino acid profiles were not different between the
unadapted and LA cells, independent of the lactate concentration in the media. A
majority of the amino acids were observed to have linear consumption profiles which
were independent of LA status and media (glutamine, histidine, isoleucine, leucine,
lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and
valine). Only glutamine was observed to be completely consumed prior to glucose
depletion. Arginine, asparagine, aspartate, and glutamate were consumed after a delay of
a couple days; however, the profiles were similar across the LA and unadapted cultures
independent of culture media. All amino acids profiles except for cysteine have been
included in Appendix A. Cysteine was not included because its concentration was below
detection for the REBEL at the dilution used on all samples.
Alanine was observed to have a significantly different profile due to media and
adaptation (p-value=0.0008) (Fig 3.4A and Appendix A-1A). The alanine profiles had
two distinct phases. Specifically, alanine was produced initially in all cultures. Then, the
alanine profiles after Day 4, either plateaued or indicated alanine consumption. The LA
cells in elevated media reached plateaus, while the unadapted and LA cells in the
standard ActiPro demonstrated consumption.
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Figure 3.5 is a simplified metabolic pathway that shows glycolysis, the TCA
cycle, and alanine and lactate reactions. In early cell growth with available glucose,
glucose is primarily shuttled consumed to generate pyruvate and is shuttled to the TCA
cycle (pink and red pathways in Fig 3.5). With this ready supply of pyruvate, there is a
supply of pyruvate for conversion to alanine (blue pathway in Fig 3.5). This conversion
explains the initial increase of alanine in the cultures. With lower glucose availability, a
significant difference in alanine and ammonia profile is observed late in culture between
cultures in standard ActiPro and those in elevated lactate media. A connection between
ammonia and alanine metabolism has been observed previously in other studies with
lactate-supplemented media (Lao & Toth, 1997; Li et al., 2012). However, a mechanism
had not been proposed related to lactate metabolism directly and elevated lactate
conditions. Alanine is derived from pyruvate as is lactate (blue and orange pathways in
Fig 3.5). There are two mechanisms for alanine synthesis and degradation from pyruvate,
the alanine aminotransferase 1 (GPT) (cytosolic) and alanine aminotransferase 2 (GPT2)
(mitochondria) pathways (Romero et al., 2004). However, from RNAseq data, only the
mitochondria version is expressed in CHO cells (Kondratova et al., 2015; Kremkow,
Baik, MacDonald, & Lee, 2015). Alanine consumption to produce pyruvate coincides
with the consumption of α-ketoglutarate to generate glutamate (blue pathway in Fig 3.5).
Glutamate in the mitochondria can be converted to α-ketoglutarate, which also yields
ammonia (green pathway in Fig 3.5) (Li et al., 2012). Therefore, alanine consumption can
lead to ammonia production. The two LA cultures in elevated lactate media had excess
lactate at the end of the cultures. In these cultures, lactate could be converted to pyruvate,
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which eliminated alanine consumption. The observed alanine plateau for the LA cultures
in lactate media is consistent with the plateau observed for ammonia.
Arginine and aspartate are common nitrogenous products of glutamine and
glutamate; thus, depletion of glutamine caused these two amino acid concentrations to
decrease after its consumption (Wu, 2010). The depletion of glutamine also leaves a need
for a nitrogen source; asparagine, which was consumed when glutamine was depleted, is
a nitrogen source used by CHO cells (Duarte et al., 2014). Arginine, asparagine, and
aspartate have also been reported to act as nitrogen signaling molecules in nitrogen
starvation meaning these amino acids could replace a role that depleted glutamine cannot
fill (Reidman, Cohen, Kupiec, & Weisman, 2019). While glutamate synthesis and
degradation occur as previously mentioned, the overall decrease of glutamate after three
days may occur due to depletion of glutamine. Glutamine is produced from glutamate by
glutamine synthetase (Zhang, Sun, Yi, & Zhang, 2006). Therefore, upon glutamine
depletion, glutamate could be consumed to produce glutamine, which has been observed
longer in fed-batch cultures (Elliott et al., 2020).
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In contrast to the majority of the consumption profiles and similar to alanine,
glycine was also produced but with a delay until Day 2. The glycine profiles were similar
across the LA and unadapted cultures regardless of the media. The increase in glycine
likely comes from serine consumption. The delayed production could be a result of
glutathione synthesis, which is made up of cysteine, glutamate, and glycine (Chevallier,
Schoof, Malphettes, Andersen, & Workman, 2020). However, this relationship is difficult
to determine without cysteine profiles. While lactate in the media allowed for lower
consumption by substitution of lactate for alanine, only cells adapted to high lactate
would survive these conditions.
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Figure 3.5: Simplified Metabolic Pathways in CHO Cells. The common three letter
abbreviations are used for all metabolites.
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CHAPTER FOUR
4
4.1

CONCLUSIONS AND FUTURE WORK

Summary and Conclusion
This work investigated the performance of cells adapted to varying levels of

lactate. The LA cells were characterized in batch growth along with unadapted cells in
standard media. Additionally, the LA cells were cultured in media at elevated lactate
concentrations equal to the concentration used for adaptation. It was hypothesized that
LA cells would have lower lactate accumulation. The unadapted and LA cells in the
standard media had similar lactate profiles. However, the lactate consumption for LA
cells in elevated media was significantly higher in the consumption phase compared to
the cells in standard media.
Lactate supplement to media resulted in slightly different final VCD; however,
the exponential growth rates are not different. The LA cells in elevated lactate exhibited
slightly lower VCD. Alanine and ammonia profiles were significantly different
depending on the lactate concentration in the media. For the LA cultures in elevated
lactate, the lactate provided a supply of pyruvate, which replaced the cell metabolic need
for alanine and associated production of ammonia. Labeling studies with alanine and
lactate could confirm these findings.
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4.2

Future Work
Future work should include fed-batch cultures to see if these effects extend into

production conditions. Studies with alternate cell lines would also prove beneficial.
Conducting work on DG44 CHO cells would allow for more direct comparison to the
work by Freund et al. (2018) and show how translatable lactate adaptation is between cell
lines. As the relationship between glycine and cysteine concentrations was not confirmed,
profiles of cysteine should be obtained. Cysteine was present, just below detection on the
Rebel with 100-fold dilution. Lower dilution would be needed to accurately quantify.
With the LA cells, more work can be completed to explore lactate induced genome
instability and whether genetic changes are maintained in culture or are random
mutations occurring.
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APPENDICES
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Appendix Introduction
The appendix A includes 19 amino acid profiles for LA and unadapted cells listed
in alphabetical order. Cysteine is not included due to its concentration being below
detection on the REBEL at the dilution used on all samples. For easier comparison, only
three y-axis scales are used (3, 6, and 9 mM).
The appendix B includes the VCD profile for LA and unadapted cells on a linear
scale. It also includes an alanine profile plotted over the IVCD. The IVCD was calculated
by using the trapezoid approximation between viable cell density points.
The appendix C includes the results of a lactate stress experiment with a control
culture and culture with gradual lactate addition.
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APPENDIX A: Amino Acids

A

B

C

D

Figure A-1: Alanine, arginine, asparagine, and aspartate profiles for Lactate-Adapted
and Unadapted Cells. A) Alanine; B) Arginine; C) Asparagine; D) Aspartate. Error bars
represent standard error.
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A

B

C

D

Figure A-2: Glutamine, glutamate, glycine, and histidine profiles for Lactate-Adapted
and Unadapted Cells. A) Glutamine; B) Glutamate; C) Glycine; D) Histidine. Error bars
represent standard error.
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B

C

D

Figure A-3: Isoleucine, leucine, lysine, and methionine profiles for Lactate-Adapted and
Unadapted Cells. A) Isoleucine; B) Leucine; C) Lysine; D) Methionine. Error bars
represent standard error.
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D

Figure A-4: Phenylalanine, proline, serine, and threonine profiles for Lactate-Adapted
and Unadapted Cells. A) Phenylalanine; B) Proline; C) Serine; D) Threonine. Error bars
represent standard error.

46

B

A

C

Figure A-5: Tryptophan, tyrosine, and valine profiles for Lactate-Adapted and
Unadapted Cells. A) Tryptophan; B) Tyrosine; C) Valine. Error bars represent standard
error.
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APPENDIX B: Supplemental Growth and Alanine Profiles

A

B

Figure B-1: Supplemental Growth and Alanine Profiles. A) VCD. B) Alanine Profile
over the Integral Viable Cell Density. The slopes of the lines indicate alanine
productivity. Positive slopes show alanine production, while negative slopes show
alanine consumption. Error bars represent standard error.
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APPENDIX C: Lactate Stress Experiment

A
B

Figure C-1: VCD and Lactate Profiles for Control and Lactate-Stressed CHO cells. A)
VCD. B) Lactate. In a previous shake flask study on CHO cells producing VRC01, a
gradual amount of lactate was added into culture and monitored. The results show
inhibited growth for lactate-supplemented cultures. Control cultures are CHO cells in
standard ActiPro.
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